Membrane Oxygenators Market Size, Share & Industry Trends, 2026–2035

Membrane Oxygenators Market Size and Growth 2026 to 2035

The global membrane oxygenators size was estimated at USD 123.91 million in 2025, is expected to surpass around USD 146.49 million by 2035, and is poised to grow at a compound annual growth rate (CAGR) of 1.69% during the forecast period of 2026 to 2035.

Key Takeaways:

• The hollow fiber membrane oxygenators segment dominated the market and accounted for the largest revenue share of 63.4% in 2025.
• The adult segment dominated the market and accounted for the largest revenue share of 56.2% in 2025.
• The respiratory segment dominated the membrane oxygenator market and accounted for the largest revenue share of 53.0% in 2025.
• North America dominated the market and accounted for the largest revenue share of 42.0% in 2025.

Market Overview

The membrane oxygenators market is an integral segment of the critical care and cardiopulmonary medical device industry. Membrane oxygenators play a vital role in extracorporeal circulation, where they facilitate gas exchange by oxygenating blood outside the body. Membrane oxygenators are used in cardiopulmonary bypass during cardiac surgery and in extracorporeal life-support systems such as VV-ECMO and VA-ECMO.

The supports underlying clinical demand for extracorporeal cardiopulmonary support”, along with the increasing incidence of conditions such as Acute Respiratory Distress Syndrome (ARDS) and COVID-19, has greatly amplified the demand for membrane oxygenators. ECMO therapy, once restricted to specialized centers, has now expanded into more mainstream critical care, particularly during the The COVID-19 pandemic increased clinical attention to ECMO for selected patients with severe respiratory failure.

Recent oxygenator development has focused on biocompatibility, gas-transfer performance, reduced priming volume, and device integration with extracorporeal support systems. Furthermore, growing healthcare investments, the increasing adoption of advanced critical care management protocols, and heightened awareness of ECMO as a therapeutic option are collectively propelling market expansion. However, challenges such as high costs, operational complexity, and skilled personnel requirements continue to influence market dynamics.

Major Trends in the Market

• Continued Use of ECMO for Severe Acute Respiratory Failure: Expanded use in intensive care units (ICUs) globally.

• Technological Advancements in Membrane Materials: Development of more biocompatible membrane and coating technologies intended to reduce thrombogenicity and improve device performance.

• Miniaturization and Portability of ECMO Systems: Creating opportunities for wider clinical adoption.

• Preference for Hollow Fiber Membrane Oxygenators: Hollow-fiber designs are widely used because they provide a large membrane surface area for gas transfer within compact oxygenator configurations..

• Rising Application in Pediatrics and Neonatal Care: Specialized oxygenators designed for young populations.

• Public-private Partnerships for ECMO Infrastructure Development: Governments and private entities enhancing critical care capabilities.

• Training and Education Initiatives: Expansion of ECMO training and competency programs remains important as programs require specialized multidisciplinary teams.

Membrane Oxygenators Market Report Scope

Driver: Rising Global Burden of Respiratory and Cardiac Diseases

One of the major drivers of the membrane oxygenators market is the escalating incidence of respiratory and cardiac diseases worldwide. Conditions such as chronic obstructive pulmonary disease (COPD), pulmonary embolism, myocarditis, and cardiogenic shock are increasingly prevalent due to aging populations, and environmental factors like pollution. For instance, the World Health Organization (WHO) reports that cardiovascular diseases are the leading cause of death globally, accounting for nearly 18 million deaths annually. Membrane oxygenators provide critical support in managing patients experiencing severe cardiac or respiratory failure, enabling effective oxygenation and carbon dioxide removal when conventional ventilation strategies fail. These clinical applications provide an underlying source of demand for membrane oxygenator systems.

Restraint: High Cost and Operational Complexity

Despite the life-saving potential of membrane oxygenators, their high cost and operational complexity, ECMO cost, staffing, equipment, or training-cost evidence from peer-reviewed or health-system sources. present significant barriers to broader market adoption. ECMO procedures, supported by membrane oxygenators, are resource-intensive, requiring expensive devices, dedicated staff, rigorous monitoring, and specialized training. Many healthcare systems, particularly in low- and middle-income countries, lack the infrastructure and trained personnel necessary to implement ECMO therapy effectively. Additionally, the cost of maintenance, consumables, and frequent training for safe device operation further add to the financial burden. This limits the accessibility of membrane oxygenator-supported therapies in underfunded regions, hampering overall market growth.

Opportunity: Expanding Role of ECMO in Emerging Markets

Emerging economies may offer expansion opportunities as ECMO capacity and critical-care infrastructure develop. for the membrane oxygenators market. As countries like India, China, Brazil, and South Africa continue to upgrade their healthcare infrastructure, the integration of advanced critical care solutions, including ECMO therapy, is gaining traction. Increased healthcare funding, expanding insurance coverage, and growing awareness of advanced life-support technologies are facilitating this transition. Furthermore, international collaborations and government initiatives to enhance ICU capacity in response to pandemics and other health crises are accelerating the adoption of ECMO systems. Products designed to reduce cost, priming volume, operational complexity, or training requirements may improve accessibility in resource-constrained settings.

By Type Insights

Hollow fiber membrane oxygenators dominated the type segment. Hollow-fiber membrane oxygenators are widely used in contemporary extracorporeal support systems. due to their superior surface area for gas exchange, biocompatibility, and long-term stability. These oxygenators offer improved blood flow dynamics, reduced hemolysis, and minimal plasma leakage. Hollow-fiber oxygenators are used in prolonged extracorporeal support, including ECMO runs lasting several days or longer depending on clinical circumstances., which can extend from days to weeks. Leading manufacturers have heavily invested in refining hollow fiber technology, further strengthening this segment's dominance.

Flat sheet membrane oxygenators are the fastest-growing segment. Although traditionally less common, flat sheet membrane oxygenators are gaining attention for specific applications requiring high oxygen transfer rates with low priming volumes. Innovations in membrane coating technologies and material science have enhanced their performance characteristics. Flat sheet designs are also being explored for portable and neonatal ECMO systems, where size, efficiency, and minimal priming volume are critical. This emerging niche application base is propelling the segment's rapid growth.

By Age Group Insights

Adults dominated the age group segment. The majority of membrane oxygenator applications cater to adult patients suffering from conditions such as myocardial infarction, ARDS, and septic shock. The high prevalence of cardiovascular and respiratory diseases among adults, coupled with broader ECMO protocol adoption in adult ICUs, cements this group's dominance.

Neonates are the fastest-growing age group segment. Neonatal applications of membrane oxygenators are expanding rapidly due to rising incidences of congenital heart defects, persistent pulmonary hypertension of the newborn (PPHN), and complications arising from preterm births. Specialized neonatal ECMO centers and broadening the therapeutic scope for neonates.

By Application Insights

Respiratory applications dominated 53.0% in 2025 the application segment. Respiratory failures, such as ARDS, COVID-19, pneumonia, and pulmonary embolism, account for a large proportion of ECMO cases utilizing membrane oxygenators. The COVID-19 pandemic alone drastically increased the deployment of respiratory ECMO, particularly for severe cases unresponsive to conventional ventilation. The continued burden of severe respiratory failure supports demand for extracorporeal respiratory support, although its effect on oxygenator demand should be assessed using utilization data..

ECPR (Extracorporeal Cardiopulmonary Resuscitation) is the fastest-growing application segment. ECPR involves the use of ECMO to support patients experiencing cardiac arrest, particularly in cases where traditional cardiopulmonary resuscitation (CPR) fails. Recent clinical studies and survival outcomes are fueling interest in expanding ECPR use beyond tertiary hospitals to emergency departments and prehospital settings. As protocols and training for ECPR become more widespread, the demand for membrane oxygenators capable of rapid deployment is experiencing swift growth.

By Regional Insights

North America dominated the membrane oxygenators market. North America's leadership is underpinned by advanced healthcare infrastructure, widespread adoption of ECMO protocols, and high awareness among critical care professionals. The United States has a substantial network of ECMO centers listed in the ELSO center directory, supported by organizations such as ELSO, which provides ECMO guidance, education, registry infrastructure, and center-recognition programs. Favorable reimbursement policies, ongoing clinical research, and robust investments in critical care technologies further solidify North America's dominant position.

Asia-Pacific is the fastest-growing region. Asia-Pacific is expected to expand at a comparatively faster rate driven by healthcare modernization, rising disposable incomes, and increasing critical care capacity. China, India, Japan, and South Korea are leading regional players investing heavily in expanding ICU and ECMO capabilities. The COVID-19 pandemic accelerated this trend, highlighting the urgent need for advanced respiratory and cardiac support systems. Local manufacturing initiatives and partnerships with international ECMO device suppliers are enhancing access to membrane oxygenators across the region.

Companies profiled in the Report include:

• Medtronic
• Fresenius SE & Co KGaA
• Getinge AB
• Terumo Medical Corporation
• MicroPort Scientific Corporation
• Nipro Medical Corporation

Segments Covered in the Report

This report analyzes historical data and forecasts revenue growth from 2026 to 2035.. For this study, Nova one advisor, Inc. has segmented the global membrane oxygenators.

By Type

• Hollow Fiber Membrane Oxygenators
• Flat Sheet Membrane Oxygenators

By Application

• Respiratory
  • Respiratory failure
  • Pulmonary embolism
  • Acute respiratory distress syndrome
  • Pneumonia
  • COVID-19
• Cardiac
  • Acute myocardial infarction
  • Myocarditis
  • Post-transplant complications
  • Decompensated cardiomyopathy
  • Cardiogenic shock
• ECPR

By Age group

• Neonates
• Pediatrics
• Adults

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)